
Pfizer signs $5.3 billion COVID-19 pill deal with US govt
Pfizer Inc (PFE.N) said on Thursday the US government would pay $5.29 billion for 10 million courses of its experimental COVID-19 antiviral drug, as the country rushes to secure promising oral ...